Home › Free Stock Grades › NVCR
Novocure Ltd (NVCR) Stock Grade
NVCR · Healthcare
A
Market Cap
$1.4B
P/E Ratio
—
Revenue Growth (YoY)
+8.3%
Net Margin
-20.8%
Return on Equity
—
Dividend Yield
None
About Novocure Ltd's fundamentals
Novocure is a medical device company with a market capitalization of $1.4 billion that generated 8.3% year-over-year revenue growth in its latest period. However, the company operates at a significant loss, with a net margin of -20.8%, reflecting ongoing unprofitability despite its top-line expansion. The company does not pay a dividend and reported a net loss in its latest annual statement, indicating it is currently reinvesting resources into operations rather than returning capital to shareholders.